Current Treatment Options in Homozygous Familial Hypercholesterolemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Treatment Options in Homozygous Familial Hypercholesterolemia
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 16, Issue 1, Pages 64
Publisher
MDPI AG
Online
2023-01-02
DOI
10.3390/ph16010064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
- (2022) Tycho R Tromp et al. LANCET
- Low density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study
- (2022) Kausik K Ray et al. European Heart Journal-Quality of Care and Clinical Outcomes
- Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
- (2022) Mohammed Al Dubayee et al. ADVANCES IN THERAPY
- Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia
- (2022) Seçil Beyece İncazli et al. Journal of Cardiovascular Nursing
- Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia
- (2022) Angela Pirillo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
- (2022) Archna Bajaj et al. Journal of Atherosclerosis and Thrombosis
- Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. CIRCULATION
- The clinical landscape for AAV gene therapies
- (2021) Dmitry A. Kuzmin et al. NATURE REVIEWS DRUG DISCOVERY
- LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
- (2021) Meral Kayikcioglu Current Atherosclerosis Reports
- Lipoprotein Metabolism in Familial Hypercholesterolemia
- (2021) Kévin Chemello et al. JOURNAL OF LIPID RESEARCH
- Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis
- (2021) R. Scott Wright et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
- (2021) Min Qiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
- (2021) Kiran Musunuru et al. NATURE
- Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
- (2021) Laura D’Erasmo et al. Orphanet Journal of Rare Diseases
- Familial Hypercholesterolemia: Global Burden and Approaches
- (2021) Lale Tokgozoglu et al. Current Cardiology Reports
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inclisiran Durably Lowers Low-Density Lipoprotein Cholesterol and Proprotein Convertase Subtilisin/Kexin Type 9 Expression in Homozygous Familial Hypercholesterolemia
- (2020) G. Kees Hovingh et al. CIRCULATION
- Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
- (2020) Özlem Kuman Tunçel et al. Journal of Clinical Lipidology
- Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
- (2020) Claudia Stefanutti Current Atherosclerosis Reports
- Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia
- (2020) Dirk J. Blom et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
- (2020) James A. Underberg et al. Journal of Clinical Lipidology
- Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia
- (2020) Meral Kayikcioglu et al. Journal of Clinical Lipidology
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
- (2019) Meral Kayikcioglu et al. Journal of Clinical Lipidology
- Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
- (2019) Tawfeg Ben-Omran et al. ADVANCES IN THERAPY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
- (2018) Meral Kayikcioglu et al. ATHEROSCLEROSIS
- Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
- (2018) Alexandra C. Chadwick et al. CIRCULATION
- Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study
- (2018) Atsushi Nohara et al. Journal of Atherosclerosis and Thrombosis
- Liver Transplantation for Homozygous Familial Hypercholesterolemia
- (2018) Yasushi Ishigaki et al. Journal of Atherosclerosis and Thrombosis
- Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
- (2017) Gilbert R Thompson et al. EUROPEAN HEART JOURNAL
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia
- (2017) Jenny A. Greig et al. Human Gene Therapy Clinical Development
- Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR+/− Rhesus Macaques
- (2017) Jenny A. Greig et al. Human Gene Therapy Clinical Development
- Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia
- (2016) Mercedes Martinez et al. AMERICAN JOURNAL OF CARDIOLOGY
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
- (2016) Michael France et al. ATHEROSCLEROSIS
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Effect of the Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody, AMG 145, in Homozygous Familial Hypercholesterolemia
- (2013) Evan A. Stein et al. CIRCULATION
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Multiple functions of microsomal triglyceride transfer protein
- (2012) M Mahmood Hussain et al. Nutrition & Metabolism
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined Hypolipidemia
- (2010) Kiran Musunuru et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
- (2010) Sadik H. Kassim et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started